Eagle Pharmaceuticals to Present at Stifel 2014 Healthcare Conference

Friday, November 7, 2014 9:40 am EST

Dateline:

WOODCLIFF LAKE, N.J.

Public Company Information:

NASDAQ:
EGRX
US2697961082

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) (“Eagle” or the “Company”) announced today that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will present at the Stifel 2014 Healthcare Conference as follows:

Date:       Wednesday, November 19, 2014
Time: 4:10 p.m. EST
Location: The New York Palace Hotel in New York City
 

The presentation will be webcast live at the aforementioned time, and archived for 90 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. The Company’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.

Contact:

In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
President

Business Wire InvestorHQsm